Dr Gordon Guyatt, Distinguished Professor at McMaster University's Department of Health Research Methods, Evidence, and Impact and one of the founders of EBM, discusses key messages from the new Canadian guidelines on opioid use in chronic noncancer pain.
Dr Parameswaran Nair, professor of medicine in the Division of Respirology at McMaster University, explains how to choose from the currently available biologics for asthma.
Dr Parameswaran Nair, professor of medicine in the Division of Respirology at McMaster University, talks about clinical trials and costs of using biologics in asthma.
Dr Parameswaran Nair, professor of medicine in the Division of Respirology at McMaster University, explains the mechanisms of action of biologics in asthma.
Dr Parameswaran Nair, professor of medicine in the Division of Respirology at McMaster University, talks about the future advances in medicine and use of benralizumab in asthma.
Dr Holger Schünemann, chair of the Department of Health, Evidence and Impact at McMaster University, discusses the WHO guideline update on multidrug-resistant tuberculosis.
Dr Gordon Guyatt, Distinguished Professor at McMaster University Department of Health Research Methods, Evidence, and Impact and one of the founders of evidence-based medicine, discusses new Canadian guidelines on opioid use in chronic noncancer pain.
Dr Holger Schünemann explains in what ways new European breast cancer screening guidelines differ from previously issued recommendations and talks about their implementation.
Dr Holger Schünemann, chair of the Department of Health, Evidence and Impact at McMaster University, on reasons and methods for developing European breast cancer screening guidelines.
In the final episode on colorectal cancer screening, Dr David Morgan discusses FIT tests and the future of screening.
English
Polski
Español
українська